Press Releases
March 12, 2019
ACTEON has entered into exclusive negotiations to acquire the Dental Division of VILLA SISTEMI MEDICALI
February 26, 2019
Debiopharm International SA Initiates a Clinical Trial Phase II study evaluating afabicin in Bone and Joint Infections
February 14, 2019
Debiopharm International SA Initiates FUZE, a Clinical Trial Phase II study evaluating Debio 1347 in Advanced Solid Tumors harboring an…
January 29, 2019
Challenge pour la Qualité de vie du patient 2019 : l’appel à projets est ouvert !
January 7, 2019
Debiopharm Group regains the commercial rights to Trelstar® (Triptorelin pamoate) and looks for new partners in North America
October 11, 2018
Debiopharm International SA and the Paul Scherrer Institute announce a licensing agreement for the development of a novel targeted radiotherapeutic…